“Article: Updated results of the phase III COLUMBUS trial further solidify BRAF/MEK combinations as standard of care for BRAF-mutated advanced melanoma” has been added to your cart. View cart
Article: A-133 EFFECT OF ABCB1 GENETIC POLYMORPHISMS ON THE TRANSPORT OF RIVAROXABAN IN HEK293 RECOMBINANT CELL LINES
A-133 EFFECT OF ABCB1 GENETIC POLYMORPHISMS ON THE TRANSPORT OF RIVAROXABAN IN HEK293 RECOMBINANT CELL LINES
Reviews
There are no reviews yet.
Be the first to review “Article: A-133 EFFECT OF ABCB1 GENETIC POLYMORPHISMS ON THE TRANSPORT OF RIVAROXABAN IN HEK293 RECOMBINANT CELL LINES” Cancel reply
Reviews
There are no reviews yet.